CHF Solutions announced the initiation of a distribution agreement in the Indian market with Wayinia Lifesciences. This agreement expands the company’s sales outreach in Asia, while opening new access to one of the larger population centers in the region. Currently, there are around three million reports of heart failure in India, with an additional one million new incidents being reported annually.